[GLUTAMIC-OXALACETIC TRANSAMINASE AND GLUTAMIC-PYRUVIC TRANSAMINASE IN ATHLETES SUBJECTED TO ANTITETANUS VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE. I].
D000410:Alanine Transaminase; D045930:Anabolic Agents; D056352:Athletes; D006801:Humans; D009277:Nandrolone; D013178:Sports Medicine; D013256:Steroids; D045165:Testosterone Congeners; D013745:Tetanus Toxoid; D000637:Transaminases; D014611:Vaccination
D045930:Anabolic Agents; D013256:Steroids; D045165:Testosterone Congeners; D013745:Tetanus Toxoid; D009277:Nandrolone; D000637:Transaminases; D000410:Alanine Transaminase
AMINOTRANSFERASES; ANABOLIC STEROIDS; SPORT MEDICINE; TETANUS TOXOID
TRANSAMINASI-GLUTAMMICO-OSSALACETICA E GLUTAMMICO-PIRUVICA IN ATLETI SOTTOPOSTI ALLA VACCINAZIONE ANTITETANICA E TRATTATI CON 4-IDROSSI-19-NORTESTOSTERONE-17-CICLOPENTILPROPIONATO. I.